Fresenius SE Comprehensive Income 2016-2024 | FSNUY

Fresenius SE comprehensive income for the quarter ending September 30, 2024 was $-0.303B, a 164.85% decline year-over-year.

  • Fresenius SE comprehensive income for 2023 was $0.019B, a 95.46% decline from 2022.
  • Fresenius SE comprehensive income for 2022 was $0.429B, a 181.27% decline from 2021.
  • Fresenius SE comprehensive income for 2021 was $-0.528B, a 59.3% decline from 2020.

Fresenius SE Comprehensive Income 2016-2024 | FSNUY

  • Fresenius SE comprehensive income for 2023 was $0.019B, a 95.46% decline from 2022.
  • Fresenius SE comprehensive income for 2022 was $0.429B, a 181.27% decline from 2021.
  • Fresenius SE comprehensive income for 2021 was $-0.528B, a 59.3% decline from 2020.
Related Stocks
Company NameMarket
Cap
Quest Diagnostics (DGX)$16.9B
DaVita (DVA)$13.6B
Encompass Health (EHC)$9.5B
Chemed (CHE)$8.3B
Elanco Animal Health (ELAN)$5.9B
Option Care Health (OPCH)$5B
RadNet (RDNT)$4.4B
LifeStance Health (LFST)$3.1B
Amedisys (AMED)$3B
Addus HomeCare (ADUS)$2.4B
Astrana Health (ASTH)$2B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$943M
Aveanna Healthcare Holdings (AVAH)$899M
Atai Life Sciences (ATAI)$245M
Bioqual (BIOQ)$58M
Daxor (DXR)$41M
Ontrak (OTRK)$7M
MEDIROM Healthcare Technologies (MRM)$5M
IMAC Holdings (BACK)$3M
Psychemedics (PMD)$0M